Advair Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials
• Forums

Clinical Endpoint Bioequivalence Study of Fluticasone Propionate & Salmeterol Xinafoate (100 μg/50μg)
Condition:   Asthma Interventions:   Drug: Fluticasone propionate/salmeterol;   Drug: Advair Diskus, 100 Mcg-50 Mcg Inhalation Powder;   Drug: Placebo Sponsor:   West-Ward Pharmaceutical Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 24, 2018 Category: Research Source Type: clinical trials

Clinical Endpoint Bioequivalence Study of Fluticasone Propionate & Salmeterol Xinafoate (100mg/50mg)
Condition:   Asthma Interventions:   Drug: Fluticasone/Salmeterol;   Drug: Advair Diskus 100/50 Dry Powder Inhaler;   Drug: Placebo Sponsors:   West-Ward Pharmaceutical;   Pharm-Olam International Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2018 Category: Research Source Type: clinical trials

Salmeterol Xinafoate and Fluticasone Propinate Powder for Inhalation for Asthma
Condition:   Asthma Interventions:   Drug: Salmeterol Xinafoate and Fluticasone Propinate Powder;   Drug: Seretide Sponsor:   Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 12, 2018 Category: Research Source Type: clinical trials